Dr Eric Fernandez will present on Virtual Tumour technology at the ACI’s Cancer Drug Discovery & Preclinical Development conference in London, UK, which is taking place 17th and 18th of September 2014....
Dr Mark Chadwick, CEO and Dr Christophe Chassagnole, COO will both present at Biotrinity 2014. Dr Chadwick will present our latest technologies in the Company showcase on the 14th of May at 13:50 and Dr Christophe Chassagnole will present on Virtual Tumour Clinical in the TSB showcase on the 13th of May at 15:20.
...
Physiomics will present a half-day workshop on “Applications of Physiomics’ Virtual Tumour Clinical within Translational Science”, on the June 10, 1:30 pm – 4:30 pm ahead of the 2014 PAGE meeting that will take place in Alicante (Spain). This workshop will review the preclinical Virtual Tumour model used to predict optimal doses and schedules of combination therapy. We will provide an overview regarding the extension...
We have an opportunity for a Biosimulation Scientist to join our technical team to work on projects related to drug development.
Find more details at our careers page....
Dr Hitesh Mistry has been accepted to present a posters at the Safety Pharmacology Society’s 13th Annual Meeting in, which will take place September 16-19 in Rotterdam, Netherlands. The poster entitled “Predicting Cardiac Toxicity from Data Generated via High-Throughput Screening” (#0023) will present the latest technology advances of the cardiac toxicity predictive platform developed at Physiomics.
...
Dr Eric Fernandez will present a poster on reducing animal experiments with the Virtual Tumour at the NC3Rs/Society of Biology 3Rs Symposium on the 19 June 2013 in London. The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is an independent scientific organisation, which supports the UK science base by driving and funding innovation and technological developments that replace or...
Dr Frances Brightman, Dr Christophe Chassagnole and Dr Eric Fernandez have been both accepted to present at this years PAGE Meeting in Glasgow. They will show an update, respectively on the cardiac toxicity platform, on the clinical virtual tumour research program and on drugCARD the anti-cancer drug combination database.
Please click here for more information on the conference.
...
